Septerna, Inc.
NASDAQ:SEPNBiotechnology
-$0.73 today
- Market cap
- $1.88B
- Beta
- 2.38
- P/E (TTM)
- -43.6
- EPS (TTM)
- -$0.81
Volume 0.30M
Average 0.32M
SEPN Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Septerna, Inc.NASDAQ: SEPN
Property, Plant & Equipment (Net) · Q3 FY2026 · quarter ended Sep 2026
Property, plant & equipment (net) falls 10.4% from a year ago
Property, plant & equipment (net) stood at $23.61M at the end of Q3 FY2026, down 10.4% from a year earlier and down 2.7% from the prior quarter. Over 3 fiscal years it compounded at +102.9% a year.
Context
- Property, plant & equipment (net) amounted to 3.8% of total assets at the end of Q3 FY2026, down 0.5 pp from a year earlier.
- Property, plant & equipment (net) increased in 2 of the last 3 fiscal years.
What to watch
Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -10.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 25.93M USD
- Year-over-year change
- -9.6%
- 3-year CAGR
- +102.9%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 25.93M | -9.6% |
| FY2024 | 2024-12-31 | 28.69M | +66.9% |
| FY2023 | 2023-12-31 | 17.19M | +453.5% |
| FY2022 | 2022-12-31 | 3.11M | — |
Property, Plant & Equipment (Net) vs competitors
How SEPN compares with its peers on the latest reported figures
- SEPN's Sep 2026 property, plant & equipment (net) of $23.61M is the 2nd highest of the 7 companies compared; the peer median is $9.63M.
- Its year-over-year change of -10.4% is the 3rd highest of 6, against a peer median of -16.8%.
- Property, plant & equipment (net) amounts to 3.8% of total assets for SEPN, versus a peer median of 0.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $23.97M | -16.8% | -15.2% | 5.7% | |
SEPNSepterna, Inc. | Sep 2026 | $23.61M | -10.4% | +102.9% | 3.8% |
| Jun 2026 | $12.39M | +13.2% | +115.3% | 0.9% | |
KLRAKailera Therapeutics, Inc. | Jun 2026 | $11.65M | — | — | 1.0% |
MBXMBX Biosciences, Inc. Common Stock | Sep 2026 | $7.61M | +201.5% | +56.4% | 1.5% |
| Mar 2026 | $67K | -99.3% | -73.2% | 0.1% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding SEPN) | $9.63M | -16.8% | +20.6% | 0.9% | |
Competitors are the stored peer set for SEPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Septerna, Inc.
NASDAQ:SEPN
Intrinsic Alpha fair value
Locked
Current Price
$39.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.